Serial Urinary 11-Dehydrathromboxane B2, Aspirin Dose, and Vascular Events in Blacks after Recent Cerebral Infarction

Askiel Bruno*, Joseph P. McConnell, Stanley N. Cohen, Gretchen E. Tietjen, Roi Ann Wallis, Philip B. Gorelick, Nils U. Bang

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Background and Purpose-Incomplete platelet inhibition by aspirin (aspirin resistance) may be a reason for stroke recurrence in some patients. 11-Dehydrothromboxane B2 (11-DTB2) is a stable thromboxane A2 metabolite that reflects in vivo platelet activation. This pilot study was intended to evaluate the reproducibility of urinary 11-DTB2 over time and to look for evidence of aspirin resistance. Methods-All subjects were screened for the African American Antiplatelet Stroke Prevention Study (AAASPS) 7 to 90 days after noncardioembolic cerebral infarction. Of 83 subjects with at least 1 urine sample, 52 were enrolled in AAASPS (randomized to blinded treatment with aspirin 650 mg/d or ticlopidine 500 mg/d), and 31 were enrolled in an open-label antiplatelet therapy cohort. Subjects were followed up for 2 years, with 11-DTB2 measurements scheduled at baseline and 6, 12, and 24 months. Vascular events were cerebral infarction, myocardial infarction, or vascular death. Results-Despite considerable individual up or down fluctuations, the median 11-DTB2 change did not significantly differ from zero in any of the subgroups. However, in 6 subjects with a 4-fold decrease in aspirin dose from 1300 to 325 or 81 mg/d, the 11-DTB2 level increased from 611 to 1881 pg/mg creatinine (P=0.06). Vascular events occurred in 7 of 61 aspirin-treated subjects, and 11-DTB2 levels did not correlate with the events. Conclusions-Fluctuations in urinary 11-DTB2 after cerebral infarction in blacks do not correlate with changes in aspirin doses, except perhaps when the dose changes by a factor of 4 or more. A larger study is needed to look further for aspirin resistance.

Original languageEnglish (US)
Pages (from-to)727-730
Number of pages4
Issue number3
StatePublished - Mar 2004


  • Aspirin
  • Cerebral infarction
  • Platelets

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing


Dive into the research topics of 'Serial Urinary 11-Dehydrathromboxane B2, Aspirin Dose, and Vascular Events in Blacks after Recent Cerebral Infarction'. Together they form a unique fingerprint.

Cite this